학술논문
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy
Document Type
Article
Author
Source
In: International Journal of Urology . (International Journal of Urology, May 2024, 31(5):526-533)
Subject
Language
English
ISSN
14422042
09198172
09198172